Претраживање
Приказ резултата 1-10 од 11
Circulating transforming growth factor-beta(1), lipoprotein(a) and cellular adhesion molecules in angiographically assessed coronary artery disease
(Walter de Gruyter & Co, Berlin, 2003)
Transforming growth factor-beta(1) (TGF-beta(1)) is involved in different physiological and pathological processes, including atherogenesis. High plasma lipoprotein(a) (Lp(a)) concentration is an established independent ...
Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay
(Walter de Gruyter Gmbh, Berlin, 2006)
Increased C-reactive protein (CRP) concentration within the reference interval ( lt 10.0 mg/L) is a strong predictor of cardiovascular disease (CVD) in apparently healthy adults. Cutoff points for use of CRP in estimating ...
Serum high sensitive c-reactive protein level in normal pregnancy and his association with body mass index
(Walter de Gruyter & Co, Berlin, 2011)
Paraoxonase-1 (PON1) activity, but not PON1(Q192R) phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population
(Walter de Gruyter Gmbh, Berlin, 2006)
Background: Paraoxonase-1 (PON1) is a high-density lipoprotein (HDL)-associated serum enzyme that protects lipoproteins from oxidative modifications. Polymorphisms in the gene, including PON1(Q192R), have been studied. ...
A retrospective study of vitamin d deficiency in Serbian population
(Walter de Gruyter & Co, Berlin, 2011)
Importance of serotonin determination in patients with esophageal and gastric fundus varices
(Walter de Gruyter & Co, Berlin, 2011)
Pregnancy levels of iron, total iron-binding capacity, transferin and ferritin
(Walter de Gruyter & Co, Berlin, 2011)
Faecal elastase 1 levels as a marker of exocrine pancreatic function in patients with diabetes mellitus
(Walter de Gruyter & Co, Berlin, 2011)
Urinary proteins as biomarkers of chronic kidney injury
(Walter de Gruyter & Co, Berlin, 2011)
Experiences in simultaneous detection of factor v leiden, factor ii g20210a, mthfr c677t and mthfr a1298c mutations in patients with thrombophilia
(Walter de Gruyter & Co, Berlin, 2011)